O	0	5	Actin	Actin	NN	B-NP
O	5	6	-	-	HYPH	O
O	6	18	sequestering	sequester	VBG	B-VP
O	19	26	protein	protein	NN	B-NP
O	26	27	,	,	,	O
O	28	36	thymosin	thymosin	NN	B-NP
O	37	41	beta	beta	SYM	B-NP
O	41	42	-	-	SYM	B-VP
O	42	43	4	4	CD	B-NP
O	43	44	,	,	,	O
O	45	47	is	be	VBZ	B-VP
O	48	49	a	a	DT	B-NP
O	50	55	novel	novel	JJ	I-NP
O	56	63	hypoxia	hypoxia	NN	I-NP
O	64	74	responsive	responsive	JJ	I-NP
O	75	84	regulator	regulator	NN	I-NP
O	84	85	.	.	.	O

O	87	99	Angiogenesis	Angiogenesis	NN	B-NP
O	100	102	is	be	VBZ	B-VP
O	103	110	induced	induce	VBN	I-VP
O	111	113	by	by	IN	B-PP
O	114	121	soluble	soluble	JJ	B-NP
O	122	129	factors	factor	NNS	I-NP
O	130	134	such	such	JJ	B-PP
O	135	137	as	as	IN	I-PP
O	138	146	vascular	vascular	JJ	B-NP
O	147	158	endothelial	endothelial	JJ	I-NP
O	159	165	growth	growth	NN	I-NP
O	166	172	factor	factor	NN	I-NP
O	173	174	(	(	(	O
O	174	178	VEGF	VEGF	NN	B-NP
O	178	179	)	)	)	O
O	180	188	released	release	VBN	B-VP
O	189	193	from	from	IN	B-PP
B-Cell	194	199	tumor	tumor	NN	B-NP
I-Cell	200	205	cells	cell	NNS	I-NP
O	206	208	in	in	IN	B-PP
O	209	216	hypoxia	hypoxia	NN	B-NP
O	216	217	.	.	.	O

O	218	220	It	It	PRP	B-NP
O	221	229	enhances	enhance	VBZ	B-VP
B-Cancer	230	235	solid	solid	JJ	B-NP
I-Cancer	236	241	tumor	tumor	NN	I-NP
O	242	248	growth	growth	NN	I-NP
O	249	252	and	and	CC	O
O	253	261	provides	provide	VBZ	B-VP
O	262	264	an	an	DT	B-NP
O	265	272	ability	ability	NN	I-NP
O	273	275	to	to	TO	B-VP
O	276	285	establish	establish	VB	I-VP
O	286	296	metastasis	metastasis	NN	B-NP
O	297	299	at	at	IN	B-PP
B-Multi-tissue_structure	300	310	peripheral	peripheral	JJ	B-NP
I-Multi-tissue_structure	311	316	sites	site	NNS	I-NP
O	317	319	by	by	IN	B-PP
B-Cell	320	325	tumor	tumor	NN	B-NP
I-Cell	326	330	cell	cell	NN	I-NP
O	331	340	migration	migration	NN	I-NP
O	340	341	.	.	.	O

O	342	350	Thymosin	Thymosin	NN	B-NP
O	351	355	beta	beta	SYM	O
O	355	356	-	-	SYM	O
O	356	357	4	4	CD	B-NP
O	358	359	(	(	(	O
O	359	362	TB4	TB4	NN	B-NP
O	362	363	)	)	)	O
O	364	366	is	be	VBZ	B-VP
O	367	369	an	an	DT	B-NP
O	370	375	actin	actin	NN	I-NP
O	375	376	-	-	HYPH	O
O	376	388	sequestering	sequester	VBG	B-VP
O	389	396	protein	protein	NN	B-NP
O	397	399	to	to	TO	B-VP
O	400	407	control	control	VB	I-VP
B-Cellular_component	408	420	cytoskeletal	cytoskeletal	JJ	B-NP
O	421	435	reorganization	reorganization	NN	I-NP
O	435	436	.	.	.	O

O	437	441	Here	Here	RB	B-ADVP
O	441	442	,	,	,	O
O	443	445	we	we	PRP	B-NP
O	446	458	investigated	investigate	VBD	B-VP
O	459	466	whether	whether	IN	B-SBAR
O	467	479	angiogenesis	angiogenesis	NN	B-NP
O	480	483	and	and	CC	I-NP
B-Cancer	484	489	tumor	tumor	NN	I-NP
O	490	500	metastasis	metastasis	NN	I-NP
O	501	504	are	be	VBP	B-VP
O	505	514	dependent	dependent	JJ	B-ADJP
O	515	517	on	on	IN	B-PP
O	518	525	hypoxia	hypoxia	NN	B-NP
O	526	538	conditioning	conditioning	NN	I-NP
O	538	539	-	-	HYPH	B-NP
O	539	546	induced	induce	VBN	I-NP
O	547	550	TB4	TB4	NN	I-NP
O	551	561	expression	expression	NN	I-NP
O	562	564	in	in	IN	B-PP
B-Cell	565	571	B16F10	B16F10	NN	B-NP
I-Cell	572	580	melanoma	melanoma	NN	I-NP
I-Cell	581	586	cells	cell	NNS	I-NP
O	586	587	.	.	.	O

O	588	591	TB4	TB4	NN	B-NP
O	592	602	expression	expression	NN	I-NP
O	603	605	in	in	IN	B-PP
B-Cell	606	612	B16F10	B16F10	NN	B-NP
I-Cell	613	618	cells	cell	NNS	I-NP
O	619	622	was	be	VBD	B-VP
O	623	632	increased	increase	VBN	I-VP
O	633	635	by	by	IN	B-PP
O	636	643	hypoxia	hypoxia	NN	B-NP
O	644	656	conditioning	condition	VBG	B-VP
O	657	659	in	in	IN	B-PP
O	660	661	a	a	DT	B-NP
O	662	666	time	time	NN	I-NP
O	666	667	-	-	HYPH	B-NP
O	667	676	dependent	dependent	JJ	I-NP
O	677	683	manner	manner	NN	I-NP
O	683	684	.	.	.	O

O	685	687	In	In	IN	B-PP
O	688	696	addition	addition	NN	B-NP
O	696	697	,	,	,	O
O	698	700	we	we	PRP	B-NP
O	701	706	found	find	VBD	B-VP
O	707	709	an	an	DT	B-NP
O	710	718	increase	increase	NN	I-NP
O	719	721	of	of	IN	B-PP
O	722	734	angiogenesis	angiogenesis	NN	B-NP
O	735	738	and	and	CC	I-NP
O	739	742	HIF	HIF	NN	I-NP
O	742	743	-	-	HYPH	B-NP
O	743	749	1alpha	1alpha	NN	I-NP
O	750	760	expression	expression	NN	I-NP
O	761	763	in	in	IN	B-PP
O	764	767	TB4	TB4	NN	B-NP
O	767	768	-	-	HYPH	B-NP
O	768	778	transgenic	transgenic	JJ	I-NP
O	779	780	(	(	(	O
O	780	782	Tg	Tg	NN	B-NP
O	782	783	)	)	)	O
O	784	788	mice	mouse	NNS	B-NP
O	789	791	as	as	IN	B-SBAR
O	792	800	compared	compare	VBN	B-VP
O	801	803	to	to	TO	B-PP
O	804	812	wildtype	wildtype	JJ	B-NP
O	813	817	mice	mouse	NNS	I-NP
O	817	818	.	.	.	O

O	819	823	When	When	WRB	B-ADVP
B-Pathological_formation	824	829	wound	wound	NN	B-NP
O	830	837	healing	healing	NN	I-NP
O	838	843	assay	assay	NN	I-NP
O	844	847	was	be	VBD	B-VP
O	848	852	used	use	VBN	I-VP
O	853	855	to	to	TO	B-VP
O	856	862	assess	assess	VB	I-VP
O	863	865	in	in	FW	B-NP
O	866	871	vitro	vitro	FW	I-NP
B-Cell	872	877	tumor	tumor	NN	I-NP
I-Cell	878	882	cell	cell	NN	I-NP
O	883	892	migration	migration	NN	I-NP
O	892	893	,	,	,	O
O	894	901	hypoxia	hypoxia	NN	B-NP
O	902	914	conditioning	condition	VBG	B-VP
O	915	918	for	for	IN	B-PP
O	919	920	1	1	CD	B-NP
O	921	922	h	h	NN	I-NP
O	923	931	enhanced	enhance	VBD	B-VP
B-Cell	932	938	B16F10	B16F10	NN	B-NP
I-Cell	939	943	cell	cell	NN	I-NP
O	944	953	migration	migration	NN	I-NP
O	953	954	.	.	.	O

O	955	959	When	When	WRB	B-ADVP
O	960	963	TB4	TB4	NN	B-NP
O	964	974	expression	expression	NN	I-NP
O	975	977	in	in	IN	B-PP
B-Cell	978	984	B16F10	B16F10	NN	B-NP
I-Cell	985	990	cells	cell	NNS	I-NP
O	991	994	was	be	VBD	B-VP
O	995	1004	inhibited	inhibit	VBN	I-VP
O	1005	1007	by	by	IN	B-PP
O	1008	1011	the	the	DT	B-NP
O	1012	1021	infection	infection	NN	I-NP
O	1022	1026	with	with	IN	B-PP
O	1027	1032	small	small	JJ	B-NP
O	1033	1040	hairpin	hairpin	NN	I-NP
O	1041	1042	(	(	(	O
O	1042	1044	sh	sh	NN	B-NP
O	1044	1045	)	)	)	O
O	1046	1049	RNA	RNA	NN	B-NP
O	1050	1052	of	of	IN	B-PP
O	1053	1056	TB4	TB4	NN	B-NP
O	1057	1063	cloned	clone	VBN	B-VP
O	1064	1066	in	in	IN	B-PP
O	1067	1077	lentiviral	lentiviral	JJ	B-NP
O	1078	1084	vector	vector	NN	I-NP
O	1084	1085	,	,	,	O
B-Cell	1086	1091	tumor	tumor	NN	B-NP
I-Cell	1092	1096	cell	cell	NN	I-NP
O	1097	1106	migration	migration	NN	I-NP
O	1107	1110	was	be	VBD	B-VP
O	1111	1119	retarded	retard	VBN	I-VP
O	1119	1120	.	.	.	O

O	1121	1123	In	In	IN	B-PP
O	1124	1132	addition	addition	NN	B-NP
O	1132	1133	,	,	,	O
O	1134	1141	hypoxia	hypoxia	NN	B-NP
O	1142	1154	conditioning	conditioning	NN	I-NP
O	1154	1155	-	-	HYPH	B-NP
O	1155	1162	induced	induce	VBN	I-NP
B-Cell	1163	1168	tumor	tumor	NN	I-NP
I-Cell	1169	1173	cell	cell	NN	I-NP
O	1174	1183	migration	migration	NN	I-NP
O	1184	1187	was	be	VBD	B-VP
O	1188	1195	reduced	reduce	VBN	I-VP
O	1196	1198	by	by	IN	B-PP
O	1199	1202	the	the	DT	B-NP
O	1203	1212	infection	infection	NN	I-NP
O	1213	1215	of	of	IN	B-PP
O	1216	1226	lentiviral	lentiviral	JJ	B-NP
O	1227	1232	shRNA	shRNA	NN	I-NP
O	1233	1235	of	of	IN	B-PP
O	1236	1239	TB4	TB4	NN	B-NP
O	1239	1240	.	.	.	O

O	1241	1244	HIF	HIF	NN	B-NP
O	1244	1245	-	-	HYPH	I-NP
O	1245	1251	1alpha	1alpha	NN	I-NP
O	1252	1265	stabilization	stabilization	NN	I-NP
O	1266	1269	and	and	CC	O
O	1270	1273	the	the	DT	B-NP
O	1274	1284	expression	expression	NN	I-NP
O	1285	1287	of	of	IN	B-PP
O	1288	1292	VEGF	VEGF	NN	B-NP
O	1293	1300	isoform	isoform	NN	I-NP
O	1301	1304	165	165	CD	B-NP
O	1305	1308	and	and	CC	I-NP
O	1309	1312	121	121	CD	I-NP
O	1313	1315	in	in	IN	B-PP
O	1316	1323	hypoxia	hypoxia	NN	B-NP
O	1324	1328	were	be	VBD	B-VP
O	1329	1333	also	also	RB	I-VP
O	1334	1341	reduced	reduce	VBN	I-VP
O	1342	1344	by	by	IN	B-PP
O	1345	1348	the	the	DT	B-NP
O	1349	1358	infection	infection	NN	I-NP
O	1359	1361	of	of	IN	B-PP
O	1362	1372	lentiviral	lentiviral	JJ	B-NP
O	1373	1378	shRNA	shRNA	NN	I-NP
O	1379	1381	of	of	IN	B-PP
O	1382	1385	TB4	TB4	NN	B-NP
O	1386	1388	in	in	IN	B-PP
B-Cell	1389	1395	B16F10	B16F10	NN	B-NP
I-Cell	1396	1401	cells	cell	NNS	I-NP
O	1401	1402	.	.	.	O

O	1403	1405	We	We	PRP	B-NP
O	1406	1410	also	also	RB	B-ADVP
O	1411	1416	found	find	VBD	B-VP
O	1417	1419	an	an	DT	B-NP
O	1420	1428	increase	increase	NN	I-NP
O	1429	1431	of	of	IN	B-PP
B-Cancer	1432	1437	tumor	tumor	NN	B-NP
O	1438	1444	growth	growth	NN	I-NP
O	1445	1448	and	and	CC	O
B-Organ	1449	1453	lung	lung	NN	B-NP
O	1454	1464	metastasis	metastasis	NN	I-NP
O	1465	1470	count	count	NN	I-NP
O	1471	1473	in	in	IN	B-PP
O	1474	1477	TB4	TB4	NN	B-NP
O	1477	1478	-	-	HYPH	B-NP
O	1478	1480	Tg	Tg	NN	I-NP
O	1481	1485	mice	mouse	NNS	I-NP
O	1486	1488	as	as	IN	B-SBAR
O	1489	1497	compared	compare	VBN	B-VP
O	1498	1500	to	to	TO	B-PP
O	1501	1509	wildtype	wildtype	JJ	B-NP
O	1510	1514	mice	mouse	NNS	I-NP
O	1514	1515	.	.	.	O

O	1516	1528	Collectively	Collectively	RB	B-ADVP
O	1528	1529	,	,	,	O
O	1530	1537	hypoxia	hypoxia	NN	B-NP
O	1538	1550	conditioning	conditioning	NN	I-NP
O	1551	1558	induced	induce	VBD	B-VP
B-Cell	1559	1564	tumor	tumor	NN	B-NP
I-Cell	1565	1569	cell	cell	NN	I-NP
O	1570	1579	migration	migration	NN	I-NP
O	1580	1582	by	by	IN	B-PP
O	1583	1586	TB4	TB4	NN	B-NP
O	1587	1597	expression	expression	NN	I-NP
O	1597	1598	-	-	HYPH	O
O	1598	1607	dependent	dependent	JJ	B-NP
O	1608	1611	HIF	HIF	NN	I-NP
O	1611	1612	-	-	HYPH	B-NP
O	1612	1618	1alpha	1alpha	NN	I-NP
O	1619	1632	stabilization	stabilization	NN	I-NP
O	1632	1633	.	.	.	O

O	1634	1636	It	It	PRP	B-NP
O	1637	1645	suggests	suggest	VBZ	B-VP
O	1646	1650	that	that	IN	B-SBAR
O	1651	1654	TB4	TB4	NN	B-NP
O	1655	1660	could	could	MD	B-VP
O	1661	1663	be	be	VB	I-VP
O	1664	1665	a	a	DT	B-NP
O	1666	1673	hypoxia	hypoxia	NN	I-NP
O	1674	1684	responsive	responsive	JJ	I-NP
O	1685	1694	regulator	regulator	NN	I-NP
O	1695	1697	to	to	TO	B-VP
O	1698	1705	control	control	VB	I-VP
B-Cell	1706	1711	tumor	tumor	NN	B-NP
I-Cell	1712	1716	cell	cell	NN	I-NP
O	1717	1726	migration	migration	NN	I-NP
O	1727	1729	in	in	IN	B-PP
O	1730	1742	angiogenesis	angiogenesis	NN	B-NP
O	1743	1746	and	and	CC	I-NP
B-Cancer	1747	1752	tumor	tumor	NN	I-NP
O	1753	1763	metastasis	metastasis	NN	I-NP
O	1763	1764	.	.	.	O

